Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 967.31
+28.31 (3.02%)
Mar 5, 2026, 8:39 AM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 60.33 million as of March 4, 2026. Its market cap has increased by 476.20% in one year.
Market Cap
60.33M
Enterprise Value
62.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
967.31
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 60.33M, an increase of 464.86%. That is a compound annual growth rate of 22.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 62.33M | 80.36% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 139.06M |
| 4basebio | 85.13M |
| Bioventix | 80.99M |
| Faron Pharmaceuticals Oy | 66.00M |
| hVIVO | 57.83M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 40.37M |
| Poolbeg Pharma | 31.73M |